NDAORALTROCHE/LOZENGE
Approved
May 2009
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
9
Mechanism of Action
Pharmacologic Class:
Cholinergic Nicotinic Agonist
Clinical Trials (5)
To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers
Started Jun 2018
37 enrolled
Tobacco Use Disorder
Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers
Started Aug 2017
76 enrolled
Tobacco Dependence
"EASY EFFECTIVE SMOKELESS" With NICORETTE®
Started Apr 2011
184 enrolled
Stereotyped BehaviorTobacco Smoking Behavior
Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum
Started Dec 2009
76 enrolled
Tobacco Dependence
Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch Treatment
Started Feb 2009
300 enrolled
Tobacco Dependence
Loss of Exclusivity
LOE Date
Jun 14, 2029
39 months away
Patent Expiry
Jun 14, 2029